CCC publication: A phase (ph) II, multi-center study of the safety and efficacy of tebentafusp (tebe) (IMCgp100) in patients (pts) with metastatic uveal melanoma (mUM)

Citation: Annals of Oncology. 2020, 31(Sup7), S1442-3

Author: J.J. Sacco, R. Carvajal, M.O. Butler, A.N. Shoushtari, J.C. Hassel, A. Ikeguchi, L. Hernandez-Aya, P. Nathan, O. Hamid, J.M. Piulats Rodriguez, M. Rioth, D.B. Johnson, J.J. Luke, E. Espinosa, S. Leyvraz, H.M. Goodall, C. Holland, S. Abdullah, T. Sato,